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Abstract: Carbapenem-resistant Klebsiella pneumoniae (CR-KP) in patients admitted to hospitals pose
a great challenge to treatment. The genes causing resistance to carbapenems are mostly found in
plasmids, mobile genetic elements that can spread easily to other bacterial strains, thus exacerbating
the problem. Here, we studied 27 CR-KP isolates collected from different types of samples from
16 patients admitted to the medical ward at Siriraj Hospital in Bangkok, Thailand, using next
generation sequencing (NGS) and optical DNA mapping (ODM). The majority of the isolates belonged
to sequence type (ST) 16 and are described in detail herein. Using ODM, we identified the plasmid
carrying the blaNDM-1 gene in the ST16 isolates and the plasmids were very similar, highlighting the
possibility of using ODM of plasmids as a surrogate marker of nosocomial spread of bacteria. We
also demonstrated that ODM could identify that the blaCTX-M-15 and blaOXA-232 genes in the ST16
isolates were encoded on separate plasmids from the blaNDM-1 gene and from each other. The other
three isolates belonged to ST147 and each of them had distinct plasmids encoding blaNDM-1.
Keywords: optical DNA mapping; plasmids; carbapenem resistance; blaNDM-1; nosocomial transmission
1. Introduction
Infections involving carbapenem-resistant Klebsiella pneumoniae (CR-KP) have be-
come a serious problem worldwide and nosocomial infections caused by CR-KP have
grown into a threatening healthcare issue in Thailand [1,2]. Broad-spectrum antibiotics,
such as extended spectrum β-lactams and carbapenems, have been the first choice in
treating hospital-acquired infections, but the widespread presence of extended spectrum
β-lactamase- (ESBL) and carbapenemase-producing strains poses a serious threat and
challenge in treating infected patients [2]. Severe misuse of antibiotics in healthcare and
animal husbandry has exacerbated the problem manifold.
The World Health Organization (WHO) has classified the South East Asian (SEA)
region as likely the most affected region in terms of antimicrobial resistance (AMR) [3].
KP is a common pathogen causing bacteremia, urinary tract infection and pneumonia in
Thailand [4–6] and the prevalence of carbapenem resistance in KP has been increasing [7–9].
A study by Lim et al. conducted in Thailand from 2004 to 2010 showed that KP was the
second most common bacterium causing bacteremia and 66% of the KP hospital-acquired
bacteremia cases were caused by multidrug-resistant (MDR) isolates. The excess mortality
by MDR bacteremia caused by six common bacteria was estimated to be 19,122 out of
45,209 (43%) deaths per year [1]. Although there has been a lot of attention towards AMR in
Antibiotics 2021, 10, 1029. https://doi.org/10.3390/antibiotics10091029 https://www.mdpi.com/journal/antibiotics
Antibiotics 2021, 10, 1029 2 of 12
recent years and surveillance studies have been conducted from time to time to understand
the severity of the issue, there is still a lot of effort needed towards understanding how
AMR spreads in the community and within healthcare and hospital settings [10].
New Delhi metallo-β-lactamase (NDM-1), identified for the first time in 2008 in
a Swedish patient returning from India, has shown a widespread presence across the
globe, including in Thailand [11–13]. The blaNDM-1 gene encodes the NDM-1 enzyme that
confers resistance to both cephalosporins and carbapenems. Plasmids play a major role
in spreading AMR, including the blaNDM-1 gene, through conjugation. The presence of
multiple resistance genes in a single plasmid is common and this makes the treatment of
infections challenging. Methods like S1-nuclease pulsed-field gel electrophoresis (PFGE)
and PCR-based replicon typing fail to provide useful information, owing to the dynamic
nature of plasmids. Next generation sequencing (NGS) has been the go-to method in recent
years, where short-read sequencing still lacks accuracy in reconstructing entire plasmid
sequences. This can be overcome by long-read sequencing, but this is still expensive and
requires bioinformatic competency.
Optical DNA mapping (ODM) is a single molecule DNA mapping technique that relies
on fluorescence imaging of single DNA molecules stretched in nanofluidic channels [14].
We have developed a protocol where one-step competitive binding labeling generates an
intensity profile along each DNA molecule, based on the underlying sequence, a DNA bar-
code [15,16]. We have applied the method extensively to plasmids and in combination with
Cas9 restriction, the gene causing the resistance can be identified [17]. The barcodes can
be used to compare plasmids between different isolates and to compare with a theoretical
sequence obtained from other sequencing techniques [18,19]. The ODM method has been
successfully used in several studies of clinical relevance, including identifying potential
conjugation during a resistance outbreak [20,21], or in patients with recurring urinary tract
infections [22,23] as well as identifying clonal spread of bacteria in a hospital setting [19].
In this study, we focused on KP isolates obtained from samples collected in patients
admitted to a large hospital in Thailand between 2018 and 2019. We combined short-
read NGS data and ODM to investigate potential clonal spread and plasmid conjugation,
focusing on plasmids carrying the blaNDM-1 gene.
2. Materials and Methods
2.1. Bacterial Isolates
Urine, fecal and sputum samples collected in 2018 and 2019 from patients admitted
to Siriraj Hospital, a 2,300-bed tertiary care university hospital in Bangkok, Thailand,
were subjected to a screening for carbapenem-resistant K. pneumoniae on CarbaID agar
(bioMérieux, Marcy l’Etoile, France) and species determined with the VITEK 2 system
(bioMérieux). From the screened samples that were positive for blaNDM-1, 27 isolates from
16 patients were included in the ODM study. All patients had been treated with currently
used empirical antibiotics before knowing that the patient carried CR-KP isolates. Among
them, nine patients had one isolate each, belonging to one of the three sample types. Five
patients had two isolates, of which three patients (P6, P7 and P11) had one isolate from
feces and the other from sputum collected on the same day, one patient (P15) had one
isolate from feces and other from urine collected on the same day and one patient (P8)
had both isolates from sputum collected three months apart. Finally, two patients (P9 and
P10) had four isolates each, two from feces and two from sputum, respectively, collected at
different time points. Here, isolates P9S_1 and P9F_2 were collected on the same day and
isolates P9F_3 and P9S_4 were collected on the same day, three weeks later. Isolates P10S_1
and P10F_2 were collected on the same day and isolates P10F_3 and P10_S4 were collected
two weeks later.
2.2. DNA Extraction and Whole Genome Sequencing
Two to three fresh pure colonies were taken from culture grown overnight and sus-
pended in 200 µL suspension buffer from the EZ1®DNATissue Kit (QIAGEN). Then,
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DNA was extracted using an EZ1 Advanced DNA Bacteria Card on the EZ1 Advanced
extraction system. Concentration of the extracted DNA was measured using Qubit™
3.0 (Waltham, MA, USA). NEXTRA-XT kits were used for library preparation and se-
quencing was performed on an Illumina HiSeq2500 microbial sequencing platform. The
raw reads were assembled using SPAdes 3.13.1 and the assembled draft genomes were
used to query databases for resistance genes and virulence genes (ResFinder (https:
//cge.cbs.dtu.dk/services/ResFinder/ accessed on 14 February 2020) and Comprehen-
sive Antimicrobial Resistance Database (CARD) (https://card.mcmaster.ca/analyze/rgi
accessed on 14 February 2020). The draft genomes were also used for in silico prediction
of capsular loci (KL) and O-lipopolysaccharide by using Kaptive/Holt lab
(https://kaptive-web.erc.monash.edu/init/default/jobs accessed on 10 June 2021). Fur-
thermore, phylogenetic relatedness of the strains was analyzed using another web tool
at the Institut Pasteur: https://bigsdb.pasteur.fr/klebsiella/klebsiella.html, accessed on
10 June 2021. Tree visualization was carried out using iTOL (https://itol.embl.de accessed
on 15 April 2020).
2.3. Plasmid Extraction
Plasmids were extracted using a NucleoBond® Xtra Midi Kit (Macherey-Nagel) plas-
mid purification protocol. Bacterial strains were inoculated into 100 mL selective medium
(Luria–Bertani with 30 µg/mL ampicillin) and incubated overnight at 37 ◦C, followed
by DNA extraction using NucleoBond Xtra Midi Kit (Macherey-Nagel). Each isolate was
pelleted by centrifugation at 7000 rpm, for 10 min at 4 ◦C. The pellet was resuspended in
resuspension buffer, lysed, and purified on columns according to the manufacturer’s recom-
mendations. The eluted plasmid DNA was precipitated with isopropanol and washed once
with 70% ethanol and dried at ambient temperature. The dried pellet was reconstituted
in 100 µL TE buffer. The DNA concentration was measured using a Qubit™ dsDNA BR
Assay Kit (ThermoFisher).
2.4. Optical DNA Mapping (ODM)
The ODM assay has been well established in our earlier studies and is shown schemat-
ically in Figure 1 [14,17,19,21,22]. Custom-made crRNAs targeting blaNDM-1 (5′ CCGCTG-
CATTGATGCTGAGC 3′), blaCTX-M-15 (5′ CCGTCGCGATGTATTAGCGT 3′) and blaOXA-232
(5′ TGGAATGAGAATAAGCAGCA 3′) genes, respectively, were used.
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Figure 1. ODM schematics. (a) Plasmids extracted from b cteria collected from pati nts (Materials and Methods).
(b) 1. Restriction of plasmids with Cas9, targeting blaNDM-1, blaCTX-M-15 or blaOXA-232 gene. 2. On -step competitive
labeling of plasmids using YOYO-1: Netropsin. 3. Imaging of stretched DNA molecules in nanofluidic devices. 4. Image
analysis to obtain barcodes or intensity profiles of DNA molecules.
DNA stretching for ODM was performed using a micro–nanofluidic device, consisting
of 120 parallel nanochannels of dimensions 100 nm (height), 150 nm (width) and 500 µm
Antibiotics 2021, 10, 1029 4 of 12
(length). Images were obtained using an inverted fluorescence microscope (Zeiss AxioOb-
server.Z1) with a 100X oil objective (Zeiss, 1.46 N.A.), FITC filter (488 nm excitation and
530/50 nm emission) and a Photometrix Evolve sCMOS camera. A nanofluidic device
with parallel nanochannels allowed us to include tens of DNA molecules in each image
(20 frames, 100 ms exposure) and a total of 15 to 20 images were collected. This process
takes 20 to 30 min, thus allowing imaging of multiple samples in one day.
The images were processed using a custom-made Matlab code. The details of the
image analysis workflow have been described in detail elsewhere [17,18]. Kymographs of
linear molecules were sorted based on their lengths. Each length group (if there were more
than one) was then checked to see if the cluster of molecules in the group has the cut at a
specific region (presence of blaNDM-1 gene) or at random sites due to light- or shear-induced
breaking (absence of the gene). The length of the molecules in the Cas9 cut cluster was
estimated using λ-DNA (48,502 bp, New England Biolabs) as a reference and are presented
in units of kilobases (kb) [24].
The average intensity profile (barcode) from each isolate was then compared against
other isolates to find if the compared barcodes matched completely, partially or were en-
tirely different. Details on the statistical framework for ODM analysis have been described
in detail in our earlier works [15,19,25]. The similarity between isolates was indexed using
p-values [19,21]. For a complete match (denoted as pcomp), barcodes of similar lengths
(within 10% length difference) were stretched to the same length. If pcomp ≤ 0.01 and the
gene location was the same, then the barcodes compared were classified as identical. Next,
the barcodes were compared using their real length (significance denoted as ppart) obtained
from our measurements. Here, the barcode of the shorter molecule was moved along the
barcode of the longer molecule to find the best match. If ppart ≤ 0.01, they matched partially
due to an insertion or deletion in one of the two compared plasmids. If both p-values were
>0.01 or if the gene location was different from other plasmids in comparison, the plasmids
were classified as different.
3. Results
KP isolates resistant to commonly used antibiotics were collected at the medical wards
at Siriraj Hospital in Bangkok, Thailand in 2018 and 2019. Short-read NGS was used to
characterize a set of KP isolates consisting of a total of 27 isolates from 16 patients. The
isolates were named with a patient number, the sample type and, if more than one isolate
was collected from a patient, they were listed in numerical order. For example, P9F_2
represents the isolate from patient 9, sample type is feces, and it is the second isolate from
patient 9. Details of all the isolates involved in this study are listed in Table 1.
AMR genes were detected using the assembled draft genome blasted to ResFinder at
the Center for Genomic Epidemiology and the Comprehensive Antimicrobial Resistance
Database (CARD). Multilocus sequence type (MLST) was determined using microSALT, an
in-house bioinformatic tool at the Department of Clinical Genomics, SciLifeLab (Stockholm,
Sweden). Most of the strains were identified as ST16 (n = 24) and ST147 (n = 3). All of them
encoded resistance genes for carbapenemases, ESBLs, aminoglycosides, fluoroquinolones,
tetracyclines and sulfonamides. All of the ST16 strains showed a similar resistome profile
that included carbapenemases (blaNDM-1 and blaOXA-232), ESBLs and other lactamases
(blaCTX-M-15, blaSHV-199, blaTEM-1A and blaOXA-9), aminoglycosides (aac(6’)-Ib, aadA1 and
aadA2), fluoroquinolones (oqxA, and oqxB), trimethoprim (dfrA12) and sulfonamides
(sul1). All strains in this study showed similar virulome profiles with virulence genes
involved in iron uptake and/or metabolism (fyuA, irp1, irp2, ybtQ) and type-3 fimbriae
(mrkA complex) were encoded by both the ST147 and ST16 strains. However, the two
sequence types differed in plasmidome, capsular type, and O-LPS profile. ST16 encoded
for KL-51 capsular type and O3b O-LPS, whereas ST147 encoded for KL-64 capsular type
and O2v1 O-LPS (Figure 2).
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Table 1. Information of K. pneumoniae isolates used in this study. Column 1 shows the isolate code
(U = Urine, S = Sputum, F = Feces), column 2 provides information on the source from which the
sample was obtained, column 3 shows the multilocus sequence type (MLST) of each isolate, column
4 shows the length of the plasmid (in kb) carrying the blaNDM-1 gene in each isolate studied using
ODM, column 5 shows the length of the plasmid (in kb) carrying the blaCTX-M-15 gene in isolates
studied using ODM and column 6 shows the length of the plasmid (in kb) carrying the blaOXA-232
















P1U_1 Urine 16 131
P2S_1 Sputum 16 136
P3F_1 Feces 16 125
P4F_1 Feces 16 130 127 76
P5S_1 Sputum 16 128 128 72
P6S_1 Sputum 16 114
P6F_2 Feces 16 121
P7S_1 Sputum 16 130
P7F_2 Feces 16 124
P8S_1 Sputum 16 134
P8S_2 Sputum 16 122
P9S_1 Sputum 16 129
P9F_2 Feces 16 128
P9F_3 Feces 16 125
P9S_4 Sputum 16 123
P10S_1 Sputum 16 130
P10F_2 Feces 16 126
P10F_3 Feces 16 130
P10S_4 Sputum 16 131
P11F_1 Feces 16 138
P11S_2 Sputum 16 132 128 77
P12F_1 Feces 16 130
P13F_1 Feces 147 55
P14U_1 Urine 16 124
P15U_1 Urine 147 52
P15F_2 Feces 147 85
P16F_1 Feces 16 122
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It is evident from the spanning tree diagr m obtained from NGS data th t all the ST16
isolates are very closely related (Figure 3a). ST16 cluster 1 has 13 isolates that are ighly
identical with no differe ce in any alleles. The remaining ST16 isolates fall in cluster 2 with
a difference of one to five alleles, which is still rather small.
Of particular interest in this study were the plasmids and we used ODM to characterize
them. By combining ODM with Cas9 targeting the blaNDM-1 gene, a plasmid carrying
blaNDM-1 was identified in all the 27 isolates studied. The length measurements that are
part of the ODM analysis showed that the plasmid carrying blaNDM-1 was ~128 kb in
all 24 ST16 isolates. In the next step, we therefore compared the barcodes for all these
isolates when stretching them to the same length (Figure 3b). We found that the barcodes
of plasmids carrying the blaNDM-1 gene were similar in 19 out of 24 of the ST16 isolates
(pcomp ≤ 0.01 and identical blaNDM-1 gene location, see Materials and Methods). Figure 3c
shows a similarity matrix, where green boxes represent pcomp ≤ 0.01, yellow boxes represent
ppart ≤ 0.01 and red boxes represent p > 0.01.
The blaNDM-1-encoding plasmid in the other isolates differed in several different ways.
P8S_1 and P8S_2 had a similar barcode to the common ST16 plasmid (pcomp ≤ 0.01), but
the blaNDM-1 gene was shifted by ~10 kb compared to the common gene location (Figure
3d). P16F_1 also had a plasmid similar to the common plasmid (pcomp ≤ 0.01), but had the
blaNDM-1 gene shifted by ~15 kb in the other direction (Figure 3d). Translocation of genes
may influence transcription and expression of genes. It was beyond the scope of the study
to investigate this further, as it is already well known that the carbapenemase gene confers
phenotypic resistance to carbapenems, which was also found in this case. Thus, there is
reason to believe that the carbapenemase gene remained fully functional. Furthermore,
NGS showed that the blaNDM-1 gene had a 100% matching identity in sequence to the
reference gene. P6S_1 (114 kb) and P6F_2 (121 kb) showed better matches to the common
plasmid when using their measured lengths (ppart ≤ 0.01), indicating that they were ~12 kb
and ~7 kb shorter than the average length of 128 kb (Figure 3e). The blaNDM-1 gene sites in
P6S_1 and P6S_2 were identical to the common ST16 plasmid.
We have recently demonstrated how ODM can be a potential tool to identify the clonal
spread of bacteria carrying the blaCTX-M-15 gene [21]. As a next step, we therefore compared
the ODM data for the blaNDM-1 encoding plasmid with the cgMLST data, focusing on the
ST16 strains. The ODM data and cgMLST data show an excellent overlap and demonstrate
that the strains with a very similar plasmid also had a very similar core genome. An
interesting observation upon comparing ODM and cgMLST data is that the three isolates
Antibiotics 2021, 10, 1029 7 of 12
P8S_1, P8S_2 and P16F_1 with a shifted gene location were also among the isolates with
higher allelic differences, three, four and five alleles, respectively, compared to the common
ST16 cluster.
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Antibiotics 2021, 10, 1029 8 of 12
When we investigated the cgMLST data for the three ST147 isolates, all of them
showed high similarity with no allelic difference (Figure 4a). On the contrary, ODM results
indicate that the plasmids are all different from each other and from the common ST16
isolates (Figure 4b). P13F_1, P15U_1 and P15F_2 are the three ST147 isolates, and they all
had unique plasmid barcodes (p > 0.01, Figure 4b). Isolate P13F_1 had a 55 kb plasmid
with the blaNDM-1 gene and, interestingly, this plasmid had a barcode identical (p = 0.02) to
the common ST16 barcode for the overlapping regions and the gene location was similar
too. The p-value was slightly higher than 0.01 owing to the large difference in lengths. For
patient P15, we had two isolates, both belonging to ST147. P15U_1 had the blaNDM-1 gene
in a 50 kb plasmid while P15F_2 had the blaNDM-1 gene in an 85 kb plasmid. A comparison
between the three ST147 isolates showed that the plasmids were of different lengths and
the gene locations were different.
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4. Discussion
The goal of the project was to analyze bacterial isolates resistant to carbapenems
collected at a large hospital in Bangkok, Thailand with particular focus on the plasmids of
the isolates. We combined NGS and ODM to identify possible clonal spread of bacteria in
the hospital.
The vast majority of the isolates belonged to ST16 and cgMLST confirmed that they
were highly similar. The strains belonging to this clone featured double carbapenemases,
blaNDM-1 and blaOXA-232, as well as blaCTX-M-15. Plasmid-mediated genes encoding resistance
to fluoroquinolones, aminoglycosides, trimethoprim and sulfonamides were also found,
resulting in a multidrug-resistant phenotype. ST16 with a combination of NDM-1 and
OXA-232 has previously been described in Italy [26]. This clone is known as a successful
clone that can also disseminate KPC [27]. The ST16 strain was of K-type 51 and featured
virulence genes related to iron uptake and metabolism, as well as type-3 fimbriae.
ODM analysis of the ST16 strains demonstrated that the same plasmid encoding
blaNDM-1 was present in 19 of the isolates. In the other five, the plasmid encoding blaNDM-1
was similar but with either a slightly different location of the blaNDM-1 gene, or a significant
difference in plasmid length. The combination of NGS and ODM data gives a strong
indication of a nosocomial spread of this strain in the hospital, since both methods show, in
complementary ways, that the isolates are highly similar. An alternative explanation for the
high prevalence of a bacterial strain with an identical plasmid found among the patients
studied could be that this strain is abundant in the community, but given the nature of
some KP clones as primarily nosocomial pathogens, this is a less likely explanation. Both
scenarios are alarming and emphasize the frequent need for studies like this to understand
the spread of resistance genes, which in turn will help the fight against antibiotic resistance.
We recently demonstrated that it is possible to identify clonal spread of bacteria by
identifying bacterial plasmids using ODM. That study was carried out for E. coli and
blaCTX-M-15, and we show here that it is also possible for KP and blaNDM-1 and blaOXA-232,
indicating that the method has general utility. The ODM can be performed on its own,
which might be interesting in lower-resource settings where sequencing might not be
feasible, but imaging using a simple microscope can be carried out.
An important feature of ODM is its capability to, in contrast to for example PCR,
determine on which plasmid in a sample a certain gene is present. This is of interest from
an epidemiological perspective, since if several genes are located on the same plasmid,
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they will conjugate together, and a single conjugation event can lead to an MDR recipient
bacterium. In this study, we confirmed, using ODM, that the blaNDM-1, blaOXA-232 and
blaCTX-M-15 genes were on three different plasmids.
Interestingly, two of the plasmids were of very similar length and it would not have
been possible to discriminate them using a method, such as PFGE, that only determines
plasmid lengths. ODM, on the other hand, readily confirmed that the two plasmids had
very different barcodes. In addition, the results further strengthen the discussion above on
the relatedness of the strains since not only was one plasmid similar between the strains,
but there were three similar plasmids in total.
ODM also allowed us to confirm that the other isolates analyzed in the outbreak
(belonging to ST147) were completely different, also regarding plasmids. This confirms
that conjugation did not occur between these two bacterial strains. More importantly, the
plasmids were also different between the three isolates, even if two of them were collected
from the same patient and they all had a very similar cgMLST. This could indicate that
ST147 is a common clone in the community setting, but more isolates would be needed to
confirm this.
5. Conclusions
In conclusion, we demonstrated that ODM of plasmids is a suitable technique to
identify nosocomial transmission of bacteria. It complements NGS by characterizing
plasmids in detail and the analysis confirms that most cases of blaNDM-1 in this study were
caused by an identical strain belonging to ST16.
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